CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project focuses on small cell lung cancer by identifying subtype-specific diagnostic and therapeutic biomarkers using advanced multiomic techniques. It aims to enhance understanding of molecular subtypes and improve patient outcomes through personalized treatment strategies.
Although small cell lung cancer (SCLC) is a particularly aggressive disease, targeted therapies have remained largely unsuccessful and there were no major therapeutic advances in the last three decades.
In the clinics, SCLC is still treated as a molecularly homogeneous malignancy.
However, recent analyses led to the classification of neuroendocrine and molecular subtypes, defined by differential expression of four key transcription regulators:
ASCL1, NEUROD1, POU2F3 and YAP1.
Our study proposal…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
NATIONAL KORANYI INSTITUTE FOR TB AND PULMONOLOGY
Hungary, Budapest
Type: Research institute
Activity type: Research Organisations
SME: No
KINETO LAB. KUTATAS-FEJLESZTESI ES TANACSADO KFT
Hungary, Budapest
Type: SME
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: Yes
Germany, Essen
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Sweden, Lund
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
